Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
IMED Biotech Unit, Clinical Discovery Unit, AstraZeneca, UK
Search for other papers by Benjamin G Challis in
Google Scholar
PubMed
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Andrew S Powlson in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Carla Pearson in
Google Scholar
PubMed
Search for other papers by Brian Y Lam in
Google Scholar
PubMed
Search for other papers by Marcella Ma in
Google Scholar
PubMed
Search for other papers by Deborah Pitfield in
Google Scholar
PubMed
Search for other papers by Giles S H Yeo in
Google Scholar
PubMed
Search for other papers by Edmund Godfrey in
Google Scholar
PubMed
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Heok K Cheow in
Google Scholar
PubMed
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by V Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Nicholas R Carroll in
Google Scholar
PubMed
Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by John R Buscombe in
Google Scholar
PubMed
Search for other papers by Helen L Simpson in
Google Scholar
PubMed
followed by a negative plasma glucose response to intravenous glucagon. We also excluded patients with a negative 72-h fast who exhibited biochemical evidence of reactive hypoglycaemia following either a prolonged (5-h) oral glucose tolerance or mixed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Search for other papers by Zida Wu in
Google Scholar
PubMed
Search for other papers by Craig E Stiles in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Dragana Miljic in
Google Scholar
PubMed
Insitute of Medical Statistics and Informatics, Belgrade, Serbia
Search for other papers by Ivan Soldatovic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Sandra Pekic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Mirjana Doknic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Milan Petakov in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Christian Strasburger in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
population-specific reference range. Preserved GH axis was defined by peak GH in ITT >5 ng/mL following a blood glucose nadir of ≤2.2 mmol/L ( 28 ). Active acromegaly was defined in the presence of clinical manifestations, unsuppressible GH in oral glucose
Search for other papers by Maria Angela D'amico in
Google Scholar
PubMed
Search for other papers by Barbara Ghinassi in
Google Scholar
PubMed
Search for other papers by Pascal Izzicupo in
Google Scholar
PubMed
Search for other papers by Lamberto Manzoli in
Google Scholar
PubMed
Search for other papers by A Di Baldassarre in
Google Scholar
PubMed
. ( doi:10.1016/j.endonu.2012.10.003 ). 56 Massironi S Conte D Sciola V Spampatti MP Ciafardini C Valenti L Rossi RE Peracchi M . Plasma chromograninA response to octreotide test: prognostic value for clinical outcome in endocrine
Search for other papers by T L C Wolters in
Google Scholar
PubMed
Division of Vascular Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by C D C C van der Heijden in
Google Scholar
PubMed
Search for other papers by N van Leeuwen in
Google Scholar
PubMed
Search for other papers by B T P Hijmans-Kersten in
Google Scholar
PubMed
Search for other papers by M G Netea in
Google Scholar
PubMed
Search for other papers by J W A Smit in
Google Scholar
PubMed
Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK
Search for other papers by D H J Thijssen in
Google Scholar
PubMed
Search for other papers by A R M M Hermus in
Google Scholar
PubMed
Search for other papers by N P Riksen in
Google Scholar
PubMed
Search for other papers by R T Netea-Maier in
Google Scholar
PubMed
and radiologically confirmed acromegaly, defined as an increased serum IGF1 level (>2 s.d. above the mean corrected for sex and age) and insufficient suppression of serum GH levels (≥0.4 µg/L) during an oral glucose tolerance test (OGTT) ( 1
Search for other papers by R A M Quax in
Google Scholar
PubMed
Search for other papers by J A M van Laar in
Google Scholar
PubMed
Search for other papers by R van Heerebeek in
Google Scholar
PubMed
Search for other papers by K Greiner in
Google Scholar
PubMed
Search for other papers by E Ben-Chetrit in
Google Scholar
PubMed
Search for other papers by M Stanford in
Google Scholar
PubMed
Search for other papers by G R Wallace in
Google Scholar
PubMed
Search for other papers by F Fortune in
Google Scholar
PubMed
Search for other papers by M Ghabra in
Google Scholar
PubMed
Search for other papers by M Soylu in
Google Scholar
PubMed
Search for other papers by J M W Hazes in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by J H Kappen in
Google Scholar
PubMed
Search for other papers by P M van Hagen in
Google Scholar
PubMed
Search for other papers by J W Koper in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
-inflammatory agents, including NSAIDs ( n =7, 36.8%), colchicine ( n =5, 26.3%), hydroxychloroquine ( n =4, 21.1%), TNF-α blockers ( n =2, 10.5%), and pentoxifylline ( n =3, 15.8%). Thalidomide, methotrexate, interferon-alfa, and octreotide were each used by one
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Srdjan Pandurevic in
Google Scholar
PubMed
Unit of Gynecology and Obstetrics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Search for other papers by Ilaria Mancini in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Dimitri Mitselman in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Matteo Magagnoli in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Rita Teglia in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Roberta Fazzeri in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Paola Dionese in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Carolina Cecchetti in
Google Scholar
PubMed
Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele, Rome, Italy
Search for other papers by Massimiliamo Caprio in
Google Scholar
PubMed
Search for other papers by Costanzo Moretti in
Google Scholar
PubMed
Search for other papers by Justyna Sicinska in
Google Scholar
PubMed
Search for other papers by Alessandro Agostini in
Google Scholar
PubMed
Search for other papers by Domenica Gazineo in
Google Scholar
PubMed
Search for other papers by Lea Godino in
Google Scholar
PubMed
Medical Department Pronokal Group, Barcelona, Spain
Search for other papers by Ignacio Sajoux in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Flaminia Fanelli in
Google Scholar
PubMed
Unit of Gynecology and Obstetrics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Search for other papers by Cristina M Meriggiola in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Uberto Pagotto in
Google Scholar
PubMed
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
://doi.org/10.1093/ajcn/77.2.331 ) 26 Moretti C Guccione L Di P Simonelli I Exacoustos C Toscano V Motta C De Leo V Petraglia F & Lenzi A . Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a
Search for other papers by Giovanni Tulipano in
Google Scholar
PubMed
, ghrelin and adipokines ( 3 ). It is well known that an oral glucose load has a rapid and transient inhibitory effect on GH secretion, most likely mediated at the hypothalamic level. Indeed, glucose does not influence GH release from in vitro cultured